“…The suggestion that central catecholaminergic pathways are involved in the development of hypertension in SHR rats mainly arises from the observation that intracerebroventricular 6hydroxydopamine (6-OHDA), a catecholamine neurotoxin, prevents the development of hypertension in young SHR rats while having little effect on blood pressure in older rats when hypertension is established (Haeusler, Finch 8i Thoenen, 1972;Finch, Haeusler & Thoenen, 1972;Erinhoff, Heller & Oparil, 1975). The selective depletion of spinal catecholamines by intraspinal or intra-cisternal 6-OHDA injection (Kubo & Hashimoto, 1978;Loewy, McKellar, Swenson & Panneton, 1980) and from forebrain regions by injections of 6-OHDA into ascending noradrenergic pathways (van den Buuse, De Jonge & Versteeg, 1983) does not prevent the development of hypertension. This suggests that catecholaminergic neurones in the hypothalamus, mesencephalon or brainstem (pons-medulla) are necessary for the development but not the maintenance of hypertension in SHR rats, and that neither descending caecholaminergic pathways to the spinal preganglionic sympathetic neurones nor major ascending pathways are important in this respect.…”